2025 XJT• Global Summer School

Pharmacoeconomics and Policy Summer Camp Enrollment（XJTISS）

【Course overview】

The 2025 XJT • Global Summer School hosted by Xi'an Jiaotong University, organized by Center for Drug Safety and Policy Research (CDSP) and Editorial Office of Pharmacoeconomics and Policy. Our distinguished international faculty includes globally acclaimed professors representing premier institutions: Tulane University (USA), McMaster University (Canada), King's College London (UK), The Chinese University of Hong Kong, City University of Hong Kong, and Xi'an Jiaotong University.

This summer program centers on cutting-edge advances in pharmacoeconomics and pharmaceutical policy research. Designed to create an interdisciplinary learning platform for global pharmaceutical students and researchers in related fields, it delivers an intensive international exchange experience.

【Lecturer Profile】

Professor Lizheng Shi

Professor Lizheng Shi serves as Director of Health Systems Analytics Research Center, Tulane University, USA. A former President of both the Chinese Health Policy and Management Society (2020-2022) and Chinese Economists Society (2014-2015), he holds a unique interdisciplinary background: Pharmacy degrees from Shanghai Medical University and Peking Union Medical College, complemented by a Master’s in Economics and a PhD in Pharmaceutical Economics & Policy from USC. His pioneering research focuses on Health Technology Assessment (HTA) and AI-driven healthcare analytics. Prof. Shi contributes as Associate Editor of Value in Health and editorial board member for key journals including Pharmacoeconomics.

Professor Yu Fang

Professor Yu Fang, National Young Talent, Ministry of Education of China; Vice Dean, School of Pharmacy, Xi'an Jiaotong University, China; Chair, ISPOR Northwest China Chapter; Vice-Chair, Pharmacy Administration Professional Committee, Chinese Pharmaceutical Association; Member, Pharmaceutical Economics Professional Committee, Chinese Pharmaceutical Association. has rich experience in organizing drug policy surveys and PE/HTA analysis. Professor Fang has published more than 200 research papers, including some published in The Lancet Infectious Diseases. Editor-in-chief of Pharmacoeconomics and Policy (P&P).

Professor Feng Xie

Professor Feng Xie, Department of Clinical Epidemiology and Biostatistics, McMaster University School of Medicine; Core Faculty, Centre for Health Economics and Policy Analysis (CHEPA); his research focuses on developing evidence-based methodologies for cost-effectiveness analysis of novel pharmaceuticals and medical devices. Principal Investigator or Co-Investigator on >100 funded projects, including grants from: European Foundation for Quality of Life Research (EuroQol)、Canadian Institutes of Health Research (CIHR)、Canadian Agency for Drugs and Technologies in Health (CADTH)、Ontario Ministry of Health (MOH).

Professor Hoi-sze Joyce You

Professor Hoi-sze Joyce You, Assistant Dean and Professor, School of Pharmacy, The Chinese University of Hong Kong. Her areas of expertise include health economics, decision tree and analysis, Markov modeling, and infectious diseases. She has dedicated extensive research to evaluating the cost-effectiveness of medical technologies for diagnosis, treatment, and prevention. Her work focuses on translating innovative medical practices into cost-effective clinical protocols and developing methodological frameworks to simulate treatment outcomes.

Associate Professor Huajie Jin

Dr Huajie Jin is a Senior Lecturer and Deputy Head of King’s Health Economics, based at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. She also holds honorary associate professorships at University College London (UCL) and the Shanghai Health Development Research Centre, as well as an adjunct associate professorship at Peking University. Dr Jin’s research primarily focuses on health economic evaluation, cost-of-illness studies, and whole disease modelling. She leads the health economic components of several large-scale clinical trials and contributes to the cost assessment of advanced medical technologies for the National Institute for Health and Care Excellence (NICE).

Assistant Professor Wai Kit Ming

Assistant Professor Wai Kit Ming, Public Health and Epidemiology, and Co-Program Leader of the MSc Public Health and Epidemiology Program, City University of Hong Kong. He is an experienced clinical physician and medical educator with over a decade of teaching and mentoring experience in medical schools. To date, he has supervised more than 100 undergraduate and graduate research students. His research over the past decade has covered topics ranging from health policy-oriented clinical research to infectious disease control and surveillance. He also holds extensive memberships in academic societies and advisory committees.

Dr. Dennis Xuan

Dr. Dennis Xuan, PhD from the Department of Healthcare Policy and Management at Tulane University School of Public Health and Tropical Medicine in New Orleans. He also earned a Master of Public Health (MPH) degree from the University of North Carolina Gillings School of Public Health at Chapel Hill. Dr. Xuan has experience in cost-effectiveness analysis, budget impact models, and patient-reported outcomes research. He has also published several peer-reviewed articles and presented abstracts at international conference on topics such as pharmacoeconomics, HTA, and real-world data analysis.

Associate Professor Minghuan Jiang

Associate Professor Minghuan Jiang, School of Pharmacy, Xi’an Jiaotong University. Adjunct Researcher, Institute for Global Health and Development, Peking University. Research Field: Pharmacoeconomics, Drug Policy, Health Technology Assessment. He was the principal investigator or participated in over 20 scientific research projects, including the National Natural Science Foundation, International Postdoctoral Exchange Fellowship Program (Talent-Introduction Program), China Postdoctoral Science Foundation (First Class), and Shaanxi Provincial Natural Science Foundation. He participated in the compilation of China’s first version of Guidelines on Vaccine Economics Evaluation. His research papers were mainly published in Lancet Global Health, American Journal of Preventive Medicine, PharmacoEconomics, Vaccine, etc. In 2022, he was awarded the first Young Scholar of Global Health Development Award Program of Peking University. He currently serves as the vice president of ISPOR Northwest China Chapter, a member of Pharmacoeconomics Professional Committee of Chinese Pharmaceutical Association, and a member of Vaccine Economics Professional Committee of China Association for Vaccines, etc.

Associate Professor Wenjing Ji

Associate Professor Wenjing Ji, Xi'an Jiaotong University. Research Fellow at Harvard University during 2017-2018. She has worked in the medical departments of top pharmaceutical companies for 6 years. The current research interest focuses on rare disease, real-world study, disease burden, drug utilization research.

【Course Schedule】

【Admission Information】

Entry Requirement: Open globally to those interested in Pharmacoeconomics and Policy, including: Undergraduates、Graduates、Industry professionals. No prior grade requirements.

Registration: Please register via the XJTU Global Education Platform: https://global.xjtudlc.com

Certificate: Participants who complete all lectures and submit a final report will receive a Certificate of Completion issued by Xi'an Jiaotong University.

【Contact Information】

For inquiries, scan the QR code below to join the WeChat group or contact us:

Jing Li

Tel: 17349018028　Email: Jing_Li@xjtu.edu.cn

School of Pharmacy, Xi 'an Jiaotong University

Chapter Center for Drug Safety and Policy Research Center, Xi 'an Jiaotong University (CDSP)

Editorial Office of Pharmacoeconomics and Policy